Clinical trial
A Single-arm, Open-label, Multi-center Study to Investigate Efficacy and Safety of Lexapro on Acute Treatment of Severe Depression
NCT01814085 is registered in ClinicalTrials.gov with Xian-Janssen Pharmaceutical Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-arm, Open-label, Multi-center Study to Investigate Efficacy and Safety of Lexapro on Acute Treatment of Severe Depression
- Lead sponsor
- Xian-Janssen Pharmaceutical Ltd.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- March 31, 2012
- Enrollment
- 225 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.